Literature DB >> 17695499

Exogenous platelet-derived growth factor (PDGF) induces human astrocytoma cell line proliferation.

E Ranza1, A Facoetti, P Morbini, E Benericetti, R Nano.   

Abstract

Platelet-derived growth factor receptors (PDGFR) regulate several processes in normal cells including cellular proliferation, differentiation and migration, and are widely expressed in a variety of malignancies. In astrocytoma, PDGF ligand and receptor are often overexpressed and PDGFR activity deregulation has been linked to pathogenesis. The issue of the functional capacity of PDGFR has only occasionally been addressed in glioma cells by measuring the proliferative response induced by exogenous PDGF. In the present study, PDGFRalpha expression was evaluated in human grade 2 and 4 astrocytoma cell lines and tissue specimens by immunocytochemistry. The receptor responsiveness to exogenous PDGF was determined in astrocytoma cells with an MTT assay. It was found that astrocytoma cells express PDGFRalpha and respond to PDGF mitogenic action in a grade-dependent manner. The receptor was found to be functional since it induced cell proliferation at different ligand concentrations. We can thus conclude that the proliferative response of human astrocytoma cells is related to their malignancy and receptor status before PDGF stimulation, suggesting a role for PDGFRalpha inhibitors as blockers of malignant cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17695499

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Molecularly targeted therapies for malignant gliomas.

Authors:  Andreas A Argyriou; Haralabos P Kalofonos
Journal:  Mol Med       Date:  2009 Mar-Apr       Impact factor: 6.354

2.  Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.

Authors:  David A Reardon; Annick Desjardins; James J Vredenburgh; James E Herndon; April Coan; Sridharan Gururangan; Katherine B Peters; Roger McLendon; Sith Sathornsumetee; Jeremy N Rich; Eric S Lipp; Dorothea Janney; Henry S Friedman
Journal:  Cancer       Date:  2012-02-27       Impact factor: 6.860

3.  The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.

Authors:  Yuya Yoshida; Mitsutoshi Nakada; Tomoya Harada; Shingo Tanaka; Takuya Furuta; Yasuhiko Hayashi; Daisuke Kita; Naoyuki Uchiyama; Yutaka Hayashi; Jun-ichiro Hamada
Journal:  J Neurooncol       Date:  2009-11-25       Impact factor: 4.130

Review 4.  Targeted therapy in gliomas.

Authors:  Mohamed Ali Hamza; Mark Gilbert
Journal:  Curr Oncol Rep       Date:  2014-04       Impact factor: 5.075

5.  ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.

Authors:  Jing Xiong; Li Zhou; Miao Yang; Yoon Lim; Yu-hong Zhu; Deng-li Fu; Zhi-wei Li; Jin-hua Zhong; Zhi-cheng Xiao; Xin-Fu Zhou
Journal:  Neuro Oncol       Date:  2013-04-10       Impact factor: 12.300

Review 6.  Eosinophils in glioblastoma biology.

Authors:  Colleen S Curran; Paul J Bertics
Journal:  J Neuroinflammation       Date:  2012-01-17       Impact factor: 8.322

7.  Evaluation of miR-362 Expression in Astrocytoma of Human Brain Tumors.

Authors:  Majid Kheirollahi; Mahdiye Moodi; Saeideh Ashouri; Parvaneh Nikpour; Mohammad Kazemi
Journal:  Adv Biomed Res       Date:  2017-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.